- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 501/24 - 7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
Patent holdings for IPC class C07D 501/24
Total number of patents in this class: 23
10-year publication summary
3
|
2
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Orchid Chemicals & Pharmaceuticals Limited | 50 |
3 |
Gladius Pharmaceuticals Corporation | 4 |
2 |
University of Wollongong | 100 |
2 |
Merck Sharp & Dohme LLC | 3748 |
2 |
The Board of Trustees of the Leland Stanford Junior University | 6441 |
1 |
DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
1 |
Meiji Seika Pharma Co., Ltd. | 249 |
1 |
Newsouth Innovations Pty Limited | 594 |
1 |
Nippon Chemical Industrial Co., Ltd. | 284 |
1 |
Orchid Research Laboratories Limited | 23 |
1 |
Otsuka Chemical Co., Ltd. | 289 |
1 |
Shionogi & Co., Ltd. | 850 |
1 |
The Texas a & M University System | 1718 |
1 |
Ventana Medical Systems, Inc. | 1032 |
1 |
Zoetis LLC | 47 |
1 |
Hng Chembio Pharmacy Co., Ltd. | 2 |
1 |
Nectar Lifesciences Limited | 6 |
1 |
Nanyang Technological University | 1 |
1 |
Other owners | 0 |